GLP-1 Drugs in Plastic Surgery: How They Affect Perioperative Outcomes

What the researchers found

Review of GLP-1 agonist implications for aesthetic surgery covers preoperative considerations, anesthesia impacts, wound healing, and body contouring outcomes.

Why it matters

These findings have significant implications for peptide-based therapeutic development and clinical practice.

The numbers in context

Prospective study of patients undergoing 360° lipoabdominoplasty comparing GLP-1 users versus non-users for complication rates.

How the study worked

Study design and methodology detailed in the full publication.

Who was studied

Patients undergoing 360° lipoabdominoplasty, comparing GLP-1 drug users to non-users

What this study cannot tell us

Study-specific limitations discussed in the full publication. Results should be interpreted within the context of study design.

How to read the evidence

Evidence assessment based on study design detailed in publication.

When this study was published

Published in 2025. Current peptide therapeutic research.

The bigger picture

This study contributes to the expanding understanding of how peptide-based therapeutics can be applied across medical specialties.

Questions still open

• What are the long-term implications?
• How do these results compare to existing evidence?
• What further research is needed?

Common questions

Read the original research

GLP-1 Agonists in Aesthetic Surgery: Implications for Perioperative Outcomes and Body Contouring Procedures.

Aesthetic plastic surgery, 49(17), 4910-4916

Citation

Albanese, Roberta; Tomaselli, Federica; Delia, Gabriele; Tambasco, Damiano. (2025). GLP-1 Agonists in Aesthetic Surgery: Implications for Perioperative Outcomes and Body Contouring Procedures.. Aesthetic plastic surgery, 49(17), 4910-4916. https://doi.org/10.1007/s00266-025-05015-3